Clinical trial
Febuxostat Versus Allopurinol Control Trial in Subjects With Gout
NCT00102440 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00102440 |
|---|---|
| Title | Febuxostat Versus Allopurinol Control Trial in Subjects With Gout |
| Official title | A Phase 3, Randomized, Multicenter Study Comparing the Safety and Efficacy of Oral Febuxostat Versus Allopurinol in Subjects With Gout |
| Acronym | FACT |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gout |
| Intervention type | Drug |
| Interventions | Febuxostat, Allopurinol |
| Enrollment | 760 |
| Start date | Jul 1, 2002 |
| Primary completion | Feb 1, 2004 |
| Completion | Feb 1, 2004 |
| First posted | Jan 31, 2005 |
| Last update posted | Feb 2, 2012 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: